1. Andersen PK, Borgan O, Gill RD, Keiding N (1993) Statistical Models Based On Counting Processes. Springer: Verlag, New York
2. André M, Mounier N, Leleu X, Sonet A, Brice P, Henry-Amar M, Tilly H, Coiffier B, Bosly A, Morel P, Haioun C, Gaulard P, Reyes F, Gisselbrecht C (2004) Second cancers and late toxicities after treatment of aggressive non-Hodgkin's lymphoma with the ACBVP regimen: a GELA cohort of 2837 patients. Blood 103: 1222–1228
3. Aviles A, Diaz-Maqueo J, Talavera A, Nambo M, Garcia E (1994) Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy. Leuk Lymphoma 15: 153–157
4. Bastion Y, Bosly A, Gisselbrecht C, Reyes F, Tilly H, Herbrecht R (1993) A randomized double-blind phase III study of filgrastim (recombinant human G-CSF) vs placebo during intensive induction chemotherapy in 55 to 59 year old patients with poor prognosis aggressive non-Hodgkin's lymphoma. Blood 82 (Suppl 1): 143a
5. Bohlius J, Reiser M, Schwarzer G, Engert A (2004) Granulopoeisis stimulating factors to prevent adverse effects in the treatment of malignant lymphoma (review). The Cochrane database of systematic reviews, Issue 3 Art No.CD003189.pub03